Logo

Venus Remedies Ltd. Share Price

Pharmaceuticals & Drugs

Venus Remedies Ltd. (INR)433.95-5.4   (-1.2%)

Exchange ScripsBSE526953NSEVENUSREMISININE411B01019

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Venus Remedies Ltd. Performance

Market performance

Open price435
High450
Volumes8586
Prev Close433.95
Low428.55
Closing date2025-06-18

Historical performance

1 Year High476.90
3 Year High476.90
5 Year High639.00
1 Year Low270.25
3 Year Low145.80
5 Year Low51.50

Venus Remedies Ltd. Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
NaN
Face Value
Face Value (₹)
P/E Ratio
P/E Ratio
Dividend Yield
Dividend Yield
N/A

Venus Remedies Ltd. Investment Returns

1 Year
15.3%
3 Years
109.6%
5 Years
736.1%
10 Years
201.5%

Venus Remedies Ltd. Technicals

IndicatorsValueSignal
5-DMA444.28Bearish
10-DMA444.86Bearish
20-DMA426.47Bullish
50-DMA360.81Bullish
100-DMA332.23Bullish
200-DMA328.3Bullish

Shareholding Pattern

FieldMar-2025Dec-2024Sep-2024Jun-2024Mar-2024
Promoters55555
Foreign Investors---------------
Domestic Investors55555
Public Investors1997719766195521960919908
Government---------------

Venus Remedies Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income11610383196
Operating Profit712703704734
Interest115130
Depreciation264323335353
Profit Before Tax446379364486
Consolidated Net Profit285266407618
Adjusted EPS21203050

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital134134134123
Total Reserves4742447042713742
Minority Interest------------
Total Non-Current Liabilities599582460581
Total Liabilities6268601157915559
Capital Work in Progress211261252251
Total Assets6268601157915559

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities3733664111318
Cash Flow from Investing Activities-72-508-167565
Cash Flow from Financing Activitie-11-6-95-1622
Net Cash Inflow / Outflow290-148149261
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 20.36.
  • 3Y Stock Price CAGR of the stock is 31.4.
  • The stock has a beta of 0.9.
  • In the last financial year, the company had an EBITDA of ₹712 Million.
  • The company generated revenue of ₹6014 Million in the previous financial year.

Venus Remedies Ltd.

433.95-5.4   (-1.2%)

Investment Amount: ₹ 1000000
Current Value: ₹ 1152130.6
No. of Shares: 2655.0
Performance:15.2%
P/L: ₹152130.6

Top Gainers

SymbolChange%
EMIL158.37(18%)
SILLYMONKS18(14%)
OPTIEMUS684.6(11%)
AAKASH9.7(11%)
PFOCUS130.98(10%)

Top Losers

SymbolChange%
ORIENTCEM253.7(-16%)
KBCGLOBAL0.55(-11%)
SHAH4.45(-10%)
MOBIKWIK244.85(-9%)
HAVISHA2.29(-9%)
SGL16.62(-9%)
IKS1703.4(-8%)
STLTECH104.55(-7%)

Similar stocks

Ind-Swift Laboratories Ltd.

45.1

103.35

May 18 - June 18

Onesource Specialty Pharma Ltd.

37.5

2195

May 18 - June 18

Concord Biotech Ltd.

34

2008.9

May 18 - June 18

Pfizer Ltd.

31.3

5792.5

May 18 - June 18

Shilpa Medicare Ltd.

29.7

917.9

May 18 - June 18

Wockhardt Ltd.

29.2

1718.5

May 18 - June 18

Strides Pharma Science Ltd.

29.1

853.8

May 18 - June 18

Emcure Pharmaceuticals Ltd.

25.8

1338.9

May 18 - June 18

Announcing Stock of the Month!

Stock of the Month
Stock of the Month